drugset / Trial / NCT02134249
Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome
RandomizedSingle-groupSingle-blindPrevention
Summary
The purpose of this study is to compare the effect of oral Diosmin to oral Cabergoline in the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women underwent intracytoplasmic sperm injection (ICSI).
Timeline
- Start
- 2014-04
- Primary completion
- 2015-09
- Completion
- 2015-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cabergoline | Small molecule | 0.5 mg | Oral |
| Comparator | Diosmin | Small molecule | 500 mg | Oral |